Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Fireweed Metals Wins Final Approval for Toronto Stock Exchange Listing

Fireweed Metals Wins Final Approval for Toronto Stock Exchange Listing

BitgetBitget2026/11/03 01:47
  • Fireweed Metals has received final approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange.
  • Common shares are expected to begin TSX trading at market open November 5, 2026, under the unchanged symbol FWZ.
  • TSXV delisting is scheduled for market close November 4, 2026.
  • Trading will continue on the OTCQX Best Market as FWEDF and the Frankfurt Stock Exchange as M0G.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fireweed Metals Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202611022046CANADANWCANADAPR_C1875) on November 03, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12